paratramol 37,5 mg/325 mg filmom obalené tablety
pharmaceuticals works polpharma s.a. - tramadol, kombinácie - 65 - analgetica - anodyna
betapres 10 mg / 75 mg kapsuly
pharmaceutical works polpharma sa - bisoprolol a kyselina acetylsalicylová - 58 - hypotensiva
betapres 5 mg / 75 mg kapsuly
pharmaceutical works polpharma sa - bisoprolol a kyselina acetylsalicylová - 58 - hypotensiva
xaloptic combi
pharmaceuticals works polpharma s.a. - timolol, kombinácie - 64 - ophthalmologica
bimican 0,3 mg/ml
pharmaceutical works polpharma sa - bimatoprost - 64 - ophthalmologica
amiptic 20 mg/ml + 5 mg/ml
pharmaceuticals works polpharma s.a. - timolol, kombinácie - 64 - ophthalmologica
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiká - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
sigletic 100 mg
zaklady farmaceutyczne polpharma sa, poľsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sigletic 50 mg
zaklady farmaceutyczne polpharma sa, poľsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sigletic 25 mg
zaklady farmaceutyczne polpharma sa, poľsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)